Patents Examined by Erich Lesser
  • Patent number: 7368448
    Abstract: Compounds of the following formula (I) wherein R1 R2, n, Ar1 and A2 are as defined in the specification, in vivo-hydrolysable precursors thereof, pharmaceutically acceptable salts thereof, the use in therapy and pharmaceutical compositions and methods of treatment using the same. The example compounds are 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives.
    Type: Grant
    Filed: April 6, 2005
    Date of Patent: May 6, 2008
    Assignee: AstraZeneca AB
    Inventor: Cathy Dantzman